TYL:NYSETyler Technologies, Inc. Analysis
Data as of 2026-09-01 - not real-time
$372.22
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Tyler Technologies, Inc. trades at $372.22, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 17.1%. Relative strength is 68.6 — approaching overbought — and the MACD signal is bullish. Recent trading has carved out support near $299.73 and resistance around $382.39.
Valuation screens as fair: a P/E of 49.8 sits above the sector average of 35.8. Sell-side targets cluster 14.6% above the current quote. Revenue is growing at 8.2% on a 13.4% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 48.6%, a beta of 0.05 and a maximum drawdown of 51.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Valuation screens as fair: a P/E of 49.8 sits above the sector average of 35.8. Sell-side targets cluster 14.6% above the current quote. Revenue is growing at 8.2% on a 13.4% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 48.6%, a beta of 0.05 and a maximum drawdown of 51.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.
Top Market Events
PLANO, Texas AP — PLANO, Texas AP — Tyler Technologies Inc.Tyler Technologies Inc TYL reports record SaaS bookings and total bookings, with SaaS revenue surging 21.Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 359.42
- MACD momentum is positive
- 30-day price change of +17.1%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 49.8 versus sector average of 35.8
- Trading above the 200-day average of 359.42
- Analyst targets imply +14.6% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 49.8 versus sector average of 35.8
- Analyst targets imply +14.6% versus the current price
- 30-day volatility of 48.6%
Key Metrics & Analysis
Financial Health
Revenue Growth8.20%
Profit Margin13.36%
P/E Ratio49.8
ROE9.73%
ROA4.18%
Debt/Equity47.91
P/B Ratio5.0
Op. Cash Flow$730.7M
Free Cash Flow$594.4M
Industry P/E35.8
Technical Analysis
TrendNeutral
RSI68.6
Support$299.73
Resistance$382.39
MA 20$336.62
MA 50$317.80
MA 200$359.42
MACDBullish
VolumeIncreasing
Fear & Greed Index93.13
Valuation
Fair Value$249.59
Target Price$426.64
Upside/Downside14.62%
GradeFair
TypeGrowth
Risk Assessment
Beta0.05
Volatility48.56%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.